Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Rudolf Brunner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|March 15, 2008
Aliskiren: the first renin inhibitor for clinical treatmentChris Jensen, Peter Herold, Hans Rudolf Brunner
American Journal of Hypertension|December 4, 2003
Volume expansion enhances plasma endothelin-1Saad Abdel-Sayed, Hans Rudolf Brunner, Juerg Nussberger
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy menAnne Zanchi, Arnaud Chiolero, Marc Maillard, et al.
American Journal of Hypertension|July 10, 2003
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjectsSaad Abdel-Sayed, Juerg Nussberger, Jean François Aubert, et al.
British Journal of Clinical Pharmacology|March 14, 2023
CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteersPaolo Mulatero, Michael Groessl, Bruno Vogt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|March 15, 2008
Aliskiren: the first renin inhibitor for clinical treatmentChris Jensen, Peter Herold, Hans Rudolf Brunner
American Journal of Hypertension|December 4, 2003
Volume expansion enhances plasma endothelin-1Saad Abdel-Sayed, Hans Rudolf Brunner, Juerg Nussberger
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy menAnne Zanchi, Arnaud Chiolero, Marc Maillard, et al.
American Journal of Hypertension|July 10, 2003
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjectsSaad Abdel-Sayed, Juerg Nussberger, Jean François Aubert, et al.
British Journal of Clinical Pharmacology|March 14, 2023
CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteersPaolo Mulatero, Michael Groessl, Bruno Vogt, et al.
Pageof 1